Quest Diagnostics Inc vs Vanguard High Dividend Yield ETF — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Vanguard High Dividend Yield ETF trades at $166.65. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals.
| DGX | VYM | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | — |
52-Week High | $238.50 | $166.14 |
52-Week Low | $173.49 | $136.63 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →